CC
MDXG icon

Cannell Capital’s MiMedx Group MDXG Stock Holding History

Cannell Capital’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.2M Buy
1,870,436
+373,250
+25% +$1.36M 4.83% 6
2026
Q1 		$5.91M Buy
1,497,186
+25,635
+2% +$129K 3.63% 12
2025
Q4 		$9.96M Sell
1,471,551
-542,289
-27% -$3.8M 4.83% 6
2025
Q3 		$14.1M Sell
2,013,840
-60,086
-3% -$418K 2.14% 9
2025
Q2 		$12.7M Sell
2,073,926
-59,034
-3% -$393K 3.79% 8
2025
Q1 		$16.2M Sell
2,132,960
-1,506,585
-41% -$12.6M 5.39% 7
2024
Q4 		$35M Buy
3,639,545
+40,235
+1% +$313K 7.18% 4
2024
Q3 		$21.3M Buy
3,599,310
+277,364
+8% +$1.84M 4.38% 8
2024
Q2 		$23M Buy
3,321,946
+888,452
+37% +$6.25M 5.21% 3
2024
Q1 		$18.7M Sell
2,433,494
-47,475
-2% -$382K 4.02% 6
2023
Q4 		$21.8M Buy
2,480,969
+207,207
+9% +$1.52M 4.72% 6
2023
Q3 		$16.6M Buy
2,273,762
+1,173,506
+107% +$8.74M 3.86% 12
2023
Q2 		$7.27M Buy
1,100,256
+696,594
+173% +$3.55M 1.45% 30
2023
Q1 		$1.38M Buy
+403,662
New +$1.56M 0.27% 44

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Cannell Capital's MDXG Position: Q2 2026 in Review

Cannell Capital increased its MiMedx Group (MDXG) stake by 25% in Q2 2026, buying an estimated $1.36M and bringing the position to 1,870,436 shares worth $7.2M. The position accounts for 4.83% of the portfolio, ranked #6.

Cannell Capital first reported a position in MDXG in Q1 2023 and has held it in 14 quarters since. The position peaked at $35M in Q4 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Cannell Capital held 1,870,436 shares of MiMedx Group worth $7.2M as of Q2 2026.
  • Cannell Capital bought 373,250 MiMedx Group shares in Q2 2026, an estimated $1.36M.
  • MiMedx Group made up 4.83% of Cannell Capital's portfolio in Q2 2026, its #6 holding.
  • Cannell Capital first reported a position in MiMedx Group in Q1 2023 and has held it in 14 quarters since.
  • Cannell Capital's MiMedx Group position peaked at $35M in Q4 2024.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Cannell Capital's 13F filing for Q2 2026, filed 18 Aug 2026.